| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/24/2004 | US20040121381 Identifying calcium channel modulators for treatment of autoimmune, inflammatory, allergenic, asthmatic and cell proliferative disorders |
| 06/24/2004 | US20040121378 Diagnostic method of selecting appropriate cancer treatments and screening method of measuring reagents and curative medicines for cancer patients |
| 06/24/2004 | US20040121377 Spatially encoded and mobile arrays of tethered lipids |
| 06/24/2004 | US20040121375 Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121370 Novel composition and methods for the treatment of immune related diseases |
| 06/24/2004 | US20040121369 includes a centralized registry that contains protocols and configuration information for both instruments and analysis applications; used to instruct data capture by the biological instruments and direct the analysis of the data |
| 06/24/2004 | US20040121365 Double and triple readout assay systems |
| 06/24/2004 | US20040121362 for drug screening following exposure of cells to cigarette smoke; for the treatment of related disorders and conditions such as emphysema and chronic bronchitis |
| 06/24/2004 | US20040121356 Microchip |
| 06/24/2004 | US20040121355 Estrogen receptor genes and utilization thereof |
| 06/24/2004 | US20040121354 System and method for detecting biological and chemical material |
| 06/24/2004 | US20040121350 System and method for identifying a panel of indicators |
| 06/24/2004 | US20040121349 Novel 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040121343 for rapid, sensitive and specific assays to be used in differentiation of various diseases that are related in terms of one or more clinical characteristics; drug screening |
| 06/24/2004 | US20040121340 investigational bioinformatics important for determining a proper course of treatment and/or irradication of the bioagent in such cases as biological warfare and facilitating the identification of potential criminal identity |
| 06/24/2004 | US20040121337 recognition entity, especially a nucleic acid recognition entity; may have arene units including iptycene units separated by acetylene linkagesbulky substituents to prevent intermolecular pi - pi interactions that can decrease luminosity; |
| 06/24/2004 | US20040121335 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | US20040121334 employs use of a single calibration/detection zone defined by a porous membrane; provides an accurate, inexpensive, and readily controllable method of determining the presence of an analyte in a test sample |
| 06/24/2004 | US20040121332 Gene finding using ordered sets |
| 06/24/2004 | US20040121331 for detecting protein-protein interactions; solid phase synthesis; kits |
| 06/24/2004 | US20040121327 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 06/24/2004 | US20040121318 for measuring the therapeutic efficacy of various HIV treatment regimes such as highly active antiretroviral therapy (HAART); microarrays; solid phase synthesis; kits |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | US20040121313 Methods for rapid detection and identification of bioagents in organs for transplantation |
| 06/24/2004 | US20040121311 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | US20040121309 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | US20040121305 Generation of efficacy, toxicity and disease signatures and methods of use thereof |
| 06/24/2004 | US20040121304 by means of an assay involving cells stably transfected with plasmids comprising in vivo tests in desired target tissues; kits |
| 06/24/2004 | US20040121066 Stamping a non-linear fluid flow path |
| 06/24/2004 | US20040120957 Use of A33 antigens JAM-it |
| 06/24/2004 | US20040120954 expression of PEX without a catalytic site of MT1-MMP on a cell surface directly prevents an association of two enzymes and inhibits the activation of proMMP-2 in a dose-dependent manner |
| 06/24/2004 | US20040120951 Human-type anti-blood coagulation factor viii antibody |
| 06/24/2004 | US20040120950 Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis |
| 06/24/2004 | US20040120943 Antithrombotic thrombin variants |
| 06/24/2004 | US20040120893 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis |
| 06/24/2004 | US20040120856 Structural units that define fluidic functions |
| 06/24/2004 | US20040120854 Silicon-wafer based devices and methods for analyzing biological material |
| 06/24/2004 | US20040120562 Automated method for image analysis of residual protein |
| 06/24/2004 | US20040120185 Biosensor and sensing cell array using the same |
| 06/24/2004 | US20040119483 Measurement of molten metal with ion conducting phase sensors by means of an electrical measuring unit |
| 06/24/2004 | US20040119141 a dielectric layer includes a mixed oxide of titanium and zirconium or titanium oxide and zirconium oxide layer arrangement and its one surface is arranged on the stimulation and/or senor device |
| 06/24/2004 | US20040119010 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 06/24/2004 | US20040118757 Magnetic separation apparatus and methods |
| 06/24/2004 | US20040118705 Electrochemical test strip having a plurality of reaction chambers and methods for using the same |
| 06/24/2004 | US20040118704 Analyte test intrument having improved versatility |
| 06/24/2004 | US20040118703 Ammonia gas sensors |
| 06/24/2004 | US20040118683 Gas sensor for SOx measurement |
| 06/24/2004 | US20040118681 bacterial periplasmic binding protein (bPBP) which is not maltose binding protein and at least one reporter group |
| 06/24/2004 | US20040118228 Heated mechanical arm |
| 06/24/2004 | US20040118226 Process as well as device for measuring a component amount released during a thermo-chemical treatment of metallic work piece from the gaseous atmosphere |
| 06/24/2004 | US20040118208 Using vacuum furnace ; melting sample; measurement vibration cycles; calibration |
| 06/24/2004 | US20040118199 Apparatus and method for determining in situ pore fluid and soil properties using multi-sensor measurement systems |
| 06/24/2004 | US20040118190 Method for measuring diffusion coefficient in conductive melts, and apparatus for measuring the same |
| 06/24/2004 | US20040118162 Method and apparatus for inspecting articles of glassware |
| 06/24/2004 | DE202004004766U1 Sensor unit for continuous corrosion monitoring of buildings has sensors, cables and carriers; cables are connection between sensors and measurement device; carrier is guide for cable |
| 06/24/2004 | DE10258674A1 Manufacturing sample carrier with points for matrix-assisted laser desorption and ionization, forms MALDI matrix points by gas phase sublimation |
| 06/24/2004 | DE10258134A1 Detection and concentration of selected material, e.g. for separating proteins from body fluids to identify biological markers, comprises selective precipitation with a lipid, lipoid or fat-soluble substance |
| 06/24/2004 | DE10257102A1 Preparing high purity cell types from stem cells, useful in drug screening and as transplantation material, by differentiation in an actively aerated bioreactor |
| 06/24/2004 | DE10256947A1 Verfahren zur Messung der Aktivität G(alpha)i- oder G(alpha)o-gekoppelter Rezeptoren mittels Ca2+-Influx in Zellen A process for measuring the activity of the G (alpha) i- or G (alpha) o-coupled receptors by means of Ca2 + influx into cells |
| 06/24/2004 | DE10256669A1 Gemisch mindestens zweier Fusionsproteine sowie ihre Herstellung und Verwendung Mixture of at least two fusion proteins and their preparation and use |
| 06/24/2004 | DE10239610B3 Verfahren zur Funktionsüberwachung von Sensoren Method for monitoring the operation of sensors |
| 06/24/2004 | CA2637250A1 Apparatus and method for processing information concerning biological condition, system, program and recording medium for managing information concerning biological condition |
| 06/24/2004 | CA2509543A1 Method for predicting the response to her2-directed therapy |
| 06/24/2004 | CA2509539A1 Method of diagnosis,treatment and useful agents for conditions characterised by modulation in the level of activin .beta.c |
| 06/24/2004 | CA2508715A1 Materials and methods relating to treatment of injury and disease to the central nervous system |
| 06/24/2004 | CA2508690A1 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 06/24/2004 | CA2508584A1 Methods for rapid identification of pathogens in humans and animals |
| 06/24/2004 | CA2508348A1 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 06/24/2004 | CA2507625A1 Particles |
| 06/24/2004 | CA2507594A1 Magnetism based nucleic acid amplification |
| 06/24/2004 | CA2507592A1 Magnetism based rapid cell separation |
| 06/24/2004 | CA2507496A1 Molecular determinants of myeloma bone disease and uses thereof |
| 06/24/2004 | CA2507236A1 Method for the detection of pathogenic gram positive bacteria from the genera staphylococcus, enterococcus and streptococcus |
| 06/24/2004 | CA2507156A1 Methods of therapy and diagnosis using targeting of cells that express lax |
| 06/24/2004 | CA2507056A1 Humidified imaging with an environmental scanning electron microscope |
| 06/24/2004 | CA2506432A1 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 06/23/2004 | EP1431763A1 Method for detecting a metabolic disease |
| 06/23/2004 | EP1431762A1 Compounds and methods for detection of carcinomas and their precursor lesions |
| 06/23/2004 | EP1431759A1 Nondestructive evaluating method for aged deterioration in austenitic stainless steel |
| 06/23/2004 | EP1431758A1 Measurement instrument and concentration measurement apparatus |
| 06/23/2004 | EP1431756A1 Sulfur component sensor and sulfur component detector |
| 06/23/2004 | EP1431753A2 Coating dry estimating method, coating dry estimating system and recording medium |
| 06/23/2004 | EP1431749A1 Luminescence detecting device and luminescence detecting microarray plate |
| 06/23/2004 | EP1431747A2 Biosensor on any substrate characterized by photothermal deflection |
| 06/23/2004 | EP1431742A1 Method and apparatus for measuring diffusion coefficient in molten metal |
| 06/23/2004 | EP1431739A1 Optical device for detecting gas in the air and associated terrestrial, mobile system |
| 06/23/2004 | EP1431738A2 Addition of odorants to gases for leak detection |
| 06/23/2004 | EP1431401A2 Method for detecting and/or quantifying a known function from a nucleic acid sample |
| 06/23/2004 | EP1431400A2 Method of detecting acid-fast bacteria using ribosomal RNA as target |
| 06/23/2004 | EP1431397A1 Method for measuring UDP-GlcNAc |
| 06/23/2004 | EP1431308A1 Enzyme phosphorylating ser46 of p53 |
| 06/23/2004 | EP1431306A1 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 06/23/2004 | EP1431298A1 Mannitol and glucitol derivatives |
| 06/23/2004 | EP1431244A1 Micrograin film and process for producing the same |
| 06/23/2004 | EP1430442A2 Confirmation sequencing |
| 06/23/2004 | EP1430437A2 Method for sequencing nucleic acids |
| 06/23/2004 | EP1430436A2 Methods for determining protein and peptide terminal sequences |
| 06/23/2004 | EP1430330A1 In situ method for determining soil liquefaction tendency and its prevention by electro-osmosis |